MAAS Expands into Healthcare and Wellness with Acquisition of Carve Group Ltd

MAAS has acquired Carve Group, expanding into the healthcare and wellness sector. The acquisition includes Zhongshen Resources Development, a provider of scarce traditional Chinese medicine resources, and Glyken Bird Nest Technology, a biotechnology factory with an annual production capacity of 10 tons of bird's nest peptides. MAAS plans to use modern biotechnology to upgrade traditional wellness products and establish a globally competitive health product and service ecosystem.

MAAS (NASDAQ: MAAS), a leading provider of intelligent technology-driven family and enterprise services, has announced a significant strategic move by acquiring Carve Group Ltd through a share-based transaction valued at $293.84 million. The acquisition positions MAAS in the healthcare and wellness sector, combining traditional medicine resources with modern biotechnology capabilities.

The acquisition involved issuing 195,894,609 Class A ordinary shares at $1.50 per share to the sellers: Golden Brighter Limited, WJ Management Company Limited, and Union Chief Limited. This deal fundamentally reshapes MAAS's business model and ownership structure, with the sellers now controlling 88.32% of the equity but only 22.22% of the voting power due to the dual-class share structure.

MAAS gains control of two key subsidiaries through this acquisition: Zhongshen Resources Development, which owns 111 mu of premium forest land with over 19,000 wild ginseng roots aged 40+ years, and Glyken Bird Nest Technology, operating a biotechnology factory with a 10-ton annual production capacity of bird's nest peptides.

This strategic pivot allows MAAS to leverage Zhongshen’s scarce medicinal resources and Glyken’s biotechnology platform to scientifically upgrade traditional wellness products. The acquisition underscores MAAS's commitment to building a globally competitive health product and service ecosystem.

The substantial dilution of existing shareholders and dramatic ownership restructuring suggest this represents a complete strategic redirection rather than a mere expansion of the existing business model.

Forward-looking statements are subject to uncertainties and risks, including changes in technology, economic conditions, and competition. Investors are cautioned not to place undue reliance upon any forward-looking statements.

References:
[1] https://www.stocktitan.net/news/MAAS/maas-announces-strategic-expansion-into-healthcare-and-wellness-with-8wf5tv6nj0b4.html